ENG and endothelial dysfunction: The anti-endoglin antibody TRC105 antagonizes endoglin co-receptor activity, ameliorates endothelial dysfunction, and targets pathological angiogenesis, consistent with the context-dependent role of endoglin in EndMT and vascular remodeling [164,165].